Small Channels, Smarter Delivery - A Practical Boost For Topical And Regenerative Approaches Microneedling is proving to be a low‑risk, clinic-friendly way to enhance topical therapies (most consistently 5% minoxidil, now…
Charting New Paths in Hair Restoration for Alopecia Awareness Month As Alopecia Awareness Month unfolds, dermatologists have an opportunity to explore the latest evidence-based strategies for hair loss —straight from…
Check Out JDD Corner’s Latest Author Spotlight When it comes to women’s hair loss, assumptions can lead us astray—and Dr. Dawn Queen is here to change the conversation. In JDD's…
Rethinking Spironolactone Dosing in Female Pattern Hair Loss Could a lower dose of spironolactone offer relief to women struggling with thinning hair? Female pattern hair loss (FPHL) is a multifactorial condition…
Author Spotlight: Dr. Natalia Neha Khosla on Health Equity, Inflammation, and Innovation in Dermatology July’s JDD Author Spotlight features Natalia Neha Khosla, MD MSc, author of the July article, “Socioeconomic…
A Closer Look at Alopecia Areata in Black Patients: Are We Missing Key Diagnostic Clues? Alopecia areata (AA) is more prevalent in patients with skin of color —but how well…
Beyond Minoxidil: Is It Time to Rethink Female Hair Loss Treatment? More than half of postmenopausal women, and a significant percentage of younger, healthy women, struggle with visible hair loss,…
Curated Hair Content: Just For You! Scarring alopecia remains a challenging and often emotionally devastating diagnosis for patients. With its potential for permanent hair loss and the frequently delayed path to…
AI-Powered Personalization for Hair Loss: A Promising Alternative? With up to 50% of women and 80% of men experiencing hair loss, many turn to generic over-the-counter solutions—often with disappointing results.…
JAK Inhibitors in Alopecia Areata: A Case for Persistence? Oral Janus kinase inhibitors (JAKi) have emerged as a promising treatment for severe alopecia areata, with FDA-approved options now available. But…
Trending Article Alopecia is more than just a cosmetic concern - it’s a significant quality-of-life issue for patients with autoimmune connective tissue diseases (ACTDs) such as SLE, MCTD, Sjogren syndrome, UCTD,…